Patents by Inventor Steven L. JOHNS

Steven L. JOHNS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY USING ACAMPROSATE AND D-CYCLOSERINE
    Publication number: 20200360316
    Abstract: The invention provides a method for treating a medical condition in a patient, the method comprising: administering to a patient in need (thereof a pharmaceutical composition comprising a therapeutically effective amount of (i) a first therapeutic agent which is acamprosate or a pharmaceutically acceptable salt thereof and (ii) a second therapeutic agent which is D-cycloserine, a salt of D-cycloserine, an ester of D-cycloserine, an alkylated D-cycloserine, or a precursor of D-cycloserine.
    Type: Application
    Filed: June 2, 2020
    Publication date: November 19, 2020
    Inventors: Steven L. JOHNS, Craig A. ERICKSON
  • Sprinkle formulations of acamprosate
    Patent number: 10709668
    Abstract: The present invention provides an orally-administrable, pharmaceutical formulation comprising: a plurality of pellets, wherein: the pellets comprise a core, a sustained release coating, and an enteric coating; and the core comprises an active ingredient and a diluent.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: July 14, 2020
    Assignee: CONFLUENCE PHARMACEUTICALS, LLC
    Inventors: Steven L. Johns, Kenneth G. Payie, Badrinath R. Doniparthi, Shivaraj B. Munianjanappa
  • SPRINKLE FORMULATIONS OF ACAMPROSATE
    Publication number: 20190046458
    Abstract: The present invention provides an orally-administrable, pharmaceutical formulation comprising: a plurality of pellets, wherein: the pellets comprise a core, a sustained release coating, and an enteric coating; and the core comprises an active ingredient and a diluent.
    Type: Application
    Filed: May 4, 2016
    Publication date: February 14, 2019
    Inventors: Steven L. JOHNS, Kenneth G. PAYIE, Badrinath R. DONIPARTHI, Shivaraj B. MUNIANJANAPPA
  • COMBINATION THERAPY USING ACAMPROSATE AND D-CYCLOSERINE
    Publication number: 20180221315
    Abstract: Described herein is a method for treating a medical condition in a patient, the method comprising: administering to a patient in need (thereof a pharmaceutical composition comprising a therapeutically effective amount of (i) a first therapeutic agent which is acamprosate or a pharmaceutically acceptable salt thereof and (ii) a second therapeutic agent which is D-cycloserine, a salt of D-cycloserine, an ester of D-cycloserine, an alkylated D-cycloserine, or a precursor of D-cycloserine.
    Type: Application
    Filed: August 4, 2016
    Publication date: August 9, 2018
    Inventors: Steven L. JOHNS, Craig A. ERICKSON